Point of care testing of Influenza A/B and RSV in an adult respiratory assessment unit is associated with improvement in isolation practices and reduction in hospital length of stay Open Access

Abstract

Every winter seasonal influenza and other viral respiratory infections increase pressure on the health services and are associated with nosocomial infection and morbidity.

To compare provision of point-of-care (POC) testing with laboratory-based testing for influenza and RSV detection on an adult respiratory assessment unit to assess the impact on isolation practices and length of stay (LOS).

Prospective interrupted ‘on-off’ study in adults admitted to the respiratory unit between December 2018 and April 2019 with a suspected respiratory tract infection. Nasopharyngeal samples were tested using either the GeneXpert rapid POC test for influenza and RSV (on-period), or were sent to the laboratory for multiplex PCR testing against a panel of 12 respiratory viruses (off-period). Outcome measures were time to patient isolation for infection control, LOS and turnaround time from admission to test results.

Of 1145 patients evaluated, 755 were tested with POC and 390 with laboratory multiplex; a respiratory virus was identified in 164 (21.7 %) and 138 (35.4 %) patients respectively. A positive POC test was associated with a shorter time to isolation (mean difference 16.9 h, <0.001), shorter LOS (mean difference 15.5 h, =0.05,) and shorter turnaround time (mean difference 28.3 h, <0.001), compared to laboratory testing.

Use of GeneXpert POC testing for Flu/RSV is associated with rapid reporting of results with significant improvements in isolation practices and reductions in LOS.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001187
2020-04-06
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/69/5/697.html?itemId=/content/journal/jmm/10.1099/jmm.0.001187&mimeType=html&fmt=ahah

References

  1. Pockett RD, Watkins J, McEwan P, Meier G. Burden of illness in UK subjects with reported respiratory infections vaccinated or unvaccinated against influenza: a retrospective observational study. PLoS One 2015; 10:e0134928 [View Article][PubMed][PubMed]
    [Google Scholar]
  2. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018; 391:1285–1300 [View Article][PubMed][PubMed]
    [Google Scholar]
  3. Lee JJ, Verbakel JY, Goyder CR, Ananthakumar T, Tan PS et al. The clinical utility of point-of-care tests for influenza in ambulatory care: a systematic review and meta-analysis. Clin Infect Dis 2019; 69:24–33 [View Article][PubMed][PubMed]
    [Google Scholar]
  4. Echavarría M, Marcone DN, Querci M, Seoane A, Ypas M et al. Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection. J Clin Virol 2018; 108:90–95 [View Article][PubMed][PubMed]
    [Google Scholar]
  5. Egilmezer E, Walker GJ, Bakthavathsalam P, Peterson JR, Gooding JJ et al. Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection. Rev Med Virol 2018; 28:e1995 [View Article][PubMed][PubMed]
    [Google Scholar]
  6. Garvey MI, Wilkinson MAC, Bradley CW, Biggs M, Reddy-Kolanu V et al. Impact of a PCR point of care test for influenza A/B on an acute medical unit in a large UK teaching hospital: results of an observational, pre and post intervention study. Antimicrob Resist Infect Control 2019; 8:120 [View Article][PubMed][PubMed]
    [Google Scholar]
  7. Pedersen CJ, Rogan DT, Yang S, Quinn JV. Using a novel rapid viral test to improve triage of emergency department patients with acute respiratory illness during flu season. J Clin Virol 2018; 108:72–76 [View Article][PubMed][PubMed]
    [Google Scholar]
  8. Rogan DT, Kochar MS, Yang S, Quinn JV. Impact of rapid molecular respiratory virus testing on real-time decision making in a pediatric emergency department. J Mol Diagn 2017; 19:460–467 [View Article][PubMed][PubMed]
    [Google Scholar]
  9. Nesher L, Tsaban G, Dreiher J, Rolston KVI, Ifergane G et al. The impact of incorporating early rapid influenza diagnosis on hospital occupancy and hospital acquired influenza. Infect Control Hosp Epidemiol 2019; 40:897–903 [View Article][PubMed][PubMed]
    [Google Scholar]
  10. Youngs J, Marshall B, Farragher M, Whitney L, Glass S et al. Implementation of influenza point-of-care testing and patient cohorting during a high-incidence season: a retrospective analysis of impact on infection prevention and control and clinical outcomes. J Hosp Infect 2019; 101:276–284 [View Article][PubMed][PubMed]
    [Google Scholar]
  11. Brooke-Pearce F, Demertzi E. Introduction of COBAS Liat influenza A/B for rapid point-of-care diagnosis of influenza infection in an acute trust. J Infect Prev 2019; 20:297-300 [View Article][PubMed][PubMed]
    [Google Scholar]
  12. Ellis JS, Zambon MC. Molecular diagnosis of influenza. Rev Med Virol 2002; 12:375–389 [View Article][PubMed][PubMed]
    [Google Scholar]
  13. Centers for Disease Control and Prevention Information on rapid molecluar assays, RT-PCR, and other molecular assays for diagnosis of influenza virus infection. Available from:. https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm#hospitalized 11 December 2019
  14. Merckx J, Wali R, Schiller I, Caya C, Gore GC et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis. Ann Intern Med 2017; 167:394–409 [View Article][PubMed][PubMed]
    [Google Scholar]
  15. Brendish NJ, Malachira AK, Armstrong L, Houghton R, Aitken S et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med 2017; 5:401–411 [View Article][PubMed][PubMed]
    [Google Scholar]
  16. Davis S, Allen AJ, O'Leary R, Power M, Price DA et al. Diagnostic accuracy and cost analysis of the Alere i Influenza A&B near-patient test using throat swabs. J Hosp Infection 2017; 97:301–309
    [Google Scholar]
  17. Rogers BB, Shankar P, Jerris RC, Kotzbauer D, Anderson EJ et al. Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med 2015; 139:636–641 [View Article][PubMed][PubMed]
    [Google Scholar]
  18. van Rijn AL, Nijhuis RHT, Bekker V, Groeneveld GH, Wessels E et al. Clinical implications of rapid ePlex respiratory pathogen panel testing compared to laboratory-developed real-time PCR. Eur J Clin Microbiol Infect Dis 2018; 37:571–577 [View Article][PubMed][PubMed]
    [Google Scholar]
  19. Blackburn RM, Frampton D, Smith CM, Fragaszy EB, Watson SJ et al. Nosocomial transmission of influenza: a retrospective cross-sectional study using next generation sequencing at a hospital in England (2012-2014). Influenza Other Respir Viruses 2019; 13:556–563 [View Article][PubMed][PubMed]
    [Google Scholar]
  20. Benirschke RC, McElvania E, Thomson RB, Kaul KL, Das S. Clinical impact of rapid point-of-care PCR influenza testing in an urgent care setting: a single-center study. J Clin Microbiol 2019; 57: [View Article][PubMed][PubMed]
    [Google Scholar]
  21. Andrews D, Chetty Y, Cooper BS, Virk M, Glass SK et al. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use. BMC Infect Dis 2017; 17:671 [View Article][PubMed][PubMed]
    [Google Scholar]
  22. Martinot M, Greigert V, Gravier S, Klein S, Eyriey M et al. Positive impact of a point-of-care molecular influenza test in the emergency department during the 2017-2018 seasonal influenza epidemic. Open Forum Infect Dis 2019; 6: [View Article][PubMed][PubMed]
    [Google Scholar]
  23. Wabe N, Li L, Lindeman R, Yimsung R, Dahm MR et al. Impact of rapid molecular diagnostic testing of respiratory viruses on outcomes of adults hospitalized with respiratory illness: a multicenter quasi-experimental study. J Clin Microbiol 2019; 57: [View Article][PubMed][PubMed]
    [Google Scholar]
  24. Rappo U, Schuetz AN, Jenkins SG, Calfee DP, Walsh TJ et al. Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients. J Clin Microbiol 2016; 54:2096–2103 [View Article][PubMed][PubMed]
    [Google Scholar]
  25. Katzen J, Kohn R, Houk JL, Ison MG. Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes. Clin Infect Dis 2019; 69:52–58 [View Article][PubMed][PubMed]
    [Google Scholar]
  26. Soto M, Sampietro-Colom L, Vilella A, Pantoja E, Asenjo M et al. Economic impact of a new rapid PCR assay for detecting influenza virus in an emergency department and hospitalized patients. PLoS One 2016; 11:e0146620 [View Article][PubMed][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001187
Loading
/content/journal/jmm/10.1099/jmm.0.001187
Loading

Data & Media loading...

Most cited Most Cited RSS feed